Morel Chantal M, Lauer Jeremy A, Evans David B
Health Policy Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London WC1E 7HT.
BMJ. 2005 Dec 3;331(7528):1299. doi: 10.1136/bmj.38639.702384.AE. Epub 2005 Nov 10.
To determine the cost effectiveness of selected malaria control interventions in the context of reaching the millennium development goals for malaria.
Generalised cost effectiveness analysis.
Efficacy data came from the literature and authors' calculations supported by expert opinion. Quantities for resource inputs came from the literature and from expert opinion; prices came from the WHO-CHOICE database.
Costs were assessed in year 2000 international dollars, and effects were assessed as disability adjusted life years averted by a 10 year implementation programme. Analysis was restricted to sub-Saharan regions where the most deadly form of malaria, Plasmodium falciparum, is most prevalent. The impact on population health for various interventions, and their combinations, was evaluated at selected coverage levels by using a state-transition model. Sensitivity analysis was done for age weights and discounting.
High coverage with artemisinin based combination treatments was found to be the most cost effective strategy for control of malaria in most countries in sub-Saharan Africa.
A much larger infusion of resources than those currently available is needed to make headway in the fight to roll back malaria. On cost effectiveness grounds, in most areas in sub-Saharan Africa greater coverage with highly effective combination treatments should be the cornerstone of malaria control. However, treatment alone can achieve less than half the total benefit obtainable through a combination of interventions-scaling up the use of impregnated mosquito nets or indoor spraying with insecticides is also critical. Intermittent presumptive treatment of pregnant women can bring a small but important additional health gain at relatively low cost.
在实现疟疾千年发展目标的背景下,确定选定疟疾控制干预措施的成本效益。
广义成本效益分析。
疗效数据来自文献以及作者在专家意见支持下的计算。资源投入量来自文献和专家意见;价格来自世卫组织-CHOICE数据库。
成本以2000年国际美元进行评估,效果以10年实施计划避免的伤残调整生命年进行评估。分析仅限于撒哈拉以南地区,在该地区最致命的疟原虫——恶性疟原虫最为流行。通过使用状态转换模型,在选定的覆盖水平下评估各种干预措施及其组合对人群健康的影响。对年龄权重和贴现进行了敏感性分析。
在撒哈拉以南非洲的大多数国家,以青蒿素为基础的联合治疗高覆盖率被发现是控制疟疾最具成本效益的策略。
要在抗击疟疾的斗争中取得进展,需要比目前可用资源大量增加投入。基于成本效益的考虑,在撒哈拉以南非洲的大多数地区,提高高效联合治疗的覆盖率应是疟疾控制的基石。然而,仅靠治疗所能实现的总效益不到通过多种干预措施组合所能获得效益的一半——扩大使用浸药蚊帐或室内喷洒杀虫剂也至关重要。对孕妇进行间歇性推定治疗可以以相对较低的成本带来虽小但重要的额外健康收益。